Researchers discovered a new gene required for pancreas development, but much to their surprise, they found that it was absent in all animals except primates.
Artificial intelligence is helping researchers fill in critical gaps in medical treatment by identifying new drug targets for more precision medicine solutions.
Slight modifications to glycoproteins reveal critical insights into disease onset, state, and progression, making them a wellspring for biomarker discovery.
The discovery of insulin and its role in diabetes began with extracting canine pancreatic secretions and culminated in the first artificial pancreas in 2016.
As bispecific antibodies emerge as therapeutic game changers, scientists leverage cutting-edge technologies to navigate their multifaceted development.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.